Fairmount Funds Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-46,823
| Closed | -$10.9M | – | 22 |
|
|
2020
Q4 | $10.9M | Hold |
46,823
| – | – | 3.89% | 12 |
|
|
2020
Q3 | $10.3M | Buy |
46,823
+3,333
| +8% | +$730K | 4.34% | 11 |
|
|
2020
Q2 | $12.4M | Buy |
43,490
+6,000
| +16% | +$1.7M | 5.51% | 9 |
|
|
2020
Q1 | $10.8M | Buy |
37,490
+10,716
| +40% | +$3.09M | 6.55% | 7 |
|
|
2019
Q4 | $7.7M | Buy |
+26,774
| New | +$7.7M | 4.67% | 10 |
|